Ordinary Adjustment | Several Solactive Indices | Effective 1.April.2020
Solactive AKTIONR China Biotech AR Index:
In the ordinary rebalancing the following index composition will be implemented:
3SBIO INC |
BEIGENE LTD-ADR |
CHINA BIOLOGIC PRODUCTS HOLD |
CSPC PHARMACEUTICAL GROUP LTD |
FIBROGEN INC |
GENSCRIPT BIOTECH CORP |
HUTCHISON CHINA MEDITECH-ADR |
LEES PHARMACEUTICAL HLDGS |
LIVZON PHARMACEUTICAL GROUP INC |
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD |
SINO BIOPHARMACEUTICAL LTD ORD |
SINOPHARM GROUP CO LTD |
WUXI BIOLOGICS CAYMAN INC |
YICHANG HEC CHANGJIANG PHA-H |
ZAI LAB LTD |
boerse.de-Champions-Defensiv-Index (BCDI):
In the ordinary rebalancing the following index composition will be implemented:
CHOCOLADEFABRIKEN LINDT & SPRUENGLI AG PARTIZIPSCH |
COMPASS GROUP PLC |
DIAGEO PLC |
ESSILORLUXOTTICA |
GIVAUDAN SA |
HANNOVER RUCK SE |
L OREAL SA |
NESTLE SA |
SCHINDLER HOLDING AG |
UNILEVER NV |
boerse.de-Champions-Defensiv-Index (BCDI):
In the ordinary rebalancing the following index composition will be implemented:
CHOCOLADEFABRIKEN LINDT & SPRUENGLI AG PARTIZIPSCH | 10.0 % |
COMPASS GROUP PLC | 10.0 % |
DIAGEO PLC | 10.0 % |
ESSILORLUXOTTICA | 10.0 % |
GIVAUDAN SA | 10.0 % |
HANNOVER RUCK SE | 10.0 % |
L OREAL SA | 10.0 % |
NESTLE SA | 10.0 % |
SCHINDLER HOLDING AG | 10.0 % |
UNILEVER NV | 10.0 % |